Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $4.93 and traded as high as $9.00. Hemispherx BioPharma shares last traded at $6.70, with a volume of 7,639 shares traded.
Hemispherx BioPharma Trading Down 20.0%
The business’s 50-day moving average is $6.70 and its 200-day moving average is $4.93.
Hemispherx BioPharma Company Profile
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Featured Stories
- Five stocks we like better than Hemispherx BioPharma
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- 3 Monster Growth Stocks to Buy Now
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Best Energy Stocks – Energy Stocks to Buy Now
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
